Edesa Biotech, Inc.
EDSA
$1.96
-$0.075-3.69%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 14.55% | 3.65% | 44.07% | 15.96% | 20.26% |
| Total Depreciation and Amortization | -46.04% | -4.22% | -3.91% | -38.07% | 66.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -50.56% | -55.97% | -81.84% | 1.20% | -53.08% |
| Change in Net Operating Assets | -4,350.00% | -156.94% | 53.94% | 5,759.13% | -95.35% |
| Cash from Operations | -43.55% | -7.87% | 34.13% | 52.55% | -5.60% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,391.08% | 98.86% | -100.00% | -83.40% | -64.21% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,168.12% | -910.53% | 55.96% | 64.97% | -484.75% |
| Cash from Financing | 6,878.22% | 577.63% | -107.61% | -85.70% | -72.31% |
| Foreign Exchange rate Adjustments | -186.29% | -491.67% | 87.31% | -116.63% | -329.07% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 940.01% | 148.12% | 8.41% | 25.18% | -83.75% |